Tsevat J
Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.
Am J Med. 1992 Jul 15;93(1A):43S-47S. doi: 10.1016/0002-9343(92)90627-n.
Cigarette smoking is the foremost preventable cause of death in the United States. Along with being a major contributor to lung cancer, chronic obstructive pulmonary disease, and cerebrovascular disease, smoking is one of several modifiable risk factors for coronary artery disease (CAD). The Coronary Heart Disease Policy Model is a computer simulation model of CAD in the United States. Using the model, one can project CAD incidence, prevalence, events, mortality, cost, cost-effectiveness, and gains in life expectancy from various risk factor modifications, including smoking interventions. The model projects that reducing the number of cigarettes smoked by 50% would increase the population-wide life expectancy of 35-year-old U.S. citizens by 0.4 year. Eliminating smoking would yield population-wide gains of 0.8 year for 35-year-old males and 0.7 year for 35-year-old females. These gains are comparable to those achieved with strict control of cholesterol levels, diastolic blood pressure, or weight. Gains for the smokers themselves would be much greater. On average, 35-year-old male smokers would live 1.2 years longer if they reduced the number of cigarettes smoked by 50%, and 2.3 years longer if they quit smoking. Females 35 years of age would live 1.5 years longer by cutting back by 50% and 2.8 years longer by quitting. These gains are equal to or greater than gains that individuals would realize by reducing serum cholesterol levels of 240-299 mg/dL to 200 mg/dL; controlling mild hypertension; or reducing weight from greater than or equal to 130% ideal body weight to ideal body weight. Gains projected by the Coronary Heart Disease Policy Model are comparable to those forecast by others, who have projected that young adults would gain approximately 0.2-8.7 years by quitting smoking, depending on their smoking history. Two studies have examined the cost-effectiveness of smoking interventions. One found that counseling smokers to quit would cost only $705-988 per year of life saved for males and $1,204-2,058 per year of life saved for females. The second study found that prescribing nicotine gum as an adjunct to counseling would cost only $4,113-6,465 per year of life saved for males and $6,880-9,473 per year of life saved for females. These cost-effectiveness ratios are more favorable than those of most other current healthcare interventions. Smoking cessation would increase population-wide life expectancy by about a year and the life expectancy of a smoker by several years.(ABSTRACT TRUNCATED AT 400 WORDS)
在美国,吸烟是首要的可预防死因。吸烟不仅是肺癌、慢性阻塞性肺疾病和脑血管疾病的主要成因,还是冠状动脉疾病(CAD)的多种可改变风险因素之一。冠心病政策模型是美国CAD的计算机模拟模型。利用该模型,可以预测CAD的发病率、患病率、事件、死亡率、成本、成本效益,以及各种风险因素改变(包括吸烟干预)对预期寿命的提升。该模型预测,将吸烟量减少50%会使35岁美国公民的全人群预期寿命增加0.4年。戒烟会使35岁男性的全人群预期寿命增加0.8年,35岁女性增加0.7年。这些提升与严格控制胆固醇水平、舒张压或体重所取得的效果相当。吸烟者自身的预期寿命提升幅度会大得多。平均而言,35岁男性吸烟者若将吸烟量减少50%,预期寿命会延长1.2年,若戒烟则会延长2.3年。35岁女性通过减少50%吸烟量预期寿命会延长1.5年,戒烟则会延长2.8年。这些提升等同于或大于个人通过将血清胆固醇水平从240 - 299毫克/分升降至200毫克/分、控制轻度高血压或将体重从大于或等于理想体重的130%减至理想体重所实现的预期寿命提升。冠心病政策模型预测的提升幅度与其他研究预测的相当,其他研究预测年轻人戒烟后预期寿命会增加约0.2 - 8.7年,具体取决于他们的吸烟史。两项研究考察了吸烟干预的成本效益。一项研究发现,劝告吸烟者戒烟,男性每挽救一年生命的成本仅为705 - 988美元,女性为1204 - 2058美元。第二项研究发现,开尼古丁口香糖作为劝告的辅助手段,男性每挽救一年生命的成本仅为4113 - 6465美元,女性为6880 - 9473美元。这些成本效益比优于当前大多数其他医疗保健干预措施。戒烟将使全人群预期寿命增加约一年,吸烟者的预期寿命增加数年。(摘要截选至400字)